


To seek to achieve long-term capital growth.
| Name | % Net Assets |
|---|---|
| Wilmington | 4.3% |
| Concurrent Technologies | 3.7% |
| Renishaw | 3.3% |
| Vebnet | 3.2% |
| System C Healthcare | 3.2% |
| NCipher | 3.1% |
| Genetix | 3.0% |
| Mama | 3.0% |
| RWS Holdings | 3.0% |
| Brooks Macdonald | 2.9% |
| Key | % Net Assets |
|---|---|
| 4.3% | |
| 3.7% | |
| 3.3% | |
| 3.2% | |
| 85.5% |
| Date | 20-Aug-2025 |
|---|---|
| Bid | 1,707.77p |
| Offer | 1,739.48p |
| Currency | GBP |
| Change | -8.23p |
| % | -0.48% |
| YTD change | -41.19p |
| YTD % | -2.33% |
| Fund Inception | 07/08/1995 |
|---|---|
| Fund Manager | Anthony Cross / Julian Fosh |
| TER | 1.66 (31-Oct-2013) |
| Minimum Investment | |
|---|---|
| Initial | £2500 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.15 |
You are here: research